What does the evidence say about Bifidobacterium Longum Sleep Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Bifidobacterium Longum Sleep Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Twenty RCTs were included, of which 15 were assessed as having a low risk of bias and five as having a high risk of bias. [Das M (2026); evidence level 1] - Overall, probiotics were associated with improvements in depression, anxiety, sleep quality, mood, cognition, quality of life, and beneficial gut microbial populations, although findings for cortisol and stress-related outcomes were inconsistent. [Das M (2026); evidence level 1] - Background Probiotic supplementation may influence mental health through the gut-brain axis, with potential effects on depression, anxiety, sleep, cognition, stress hormones, and gut microbial composition. [Das M (2026); evidence level 1] - This systematic review aimed to evaluate the effects of probiotics on psychological, physiological, and gut microbiome-related outcomes across diverse populations. [Das M (2026); evidence level 1] - Among the measured SCFAs, only the butyric acid concentration in PG increased significantly during supplementation (baseline vs. [Drzymała S (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.